Analystreport

Editas Medicine, Inc. (NASDAQ: EDIT) had its price target lowered by analysts at Truist Financial Co. from $80.00 to $35.00.

Editas Medicine, Inc.  (EDIT) 
Last editas medicine, inc. earnings: 2/26 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.editasmedicine.com